HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Revlon

This article was originally published in The Rose Sheet

Executive Summary

Stephanie Klein-Peponis tapped as exec VP, chief marketing officer, effective immediately, Revlon announces. Exec promoted from role as exec VP, chief planning and business development officer, a position she has held since June (1"The Rose Sheet" June 2, 2003, In Brief). Klein-Peponis succeeds Chief Marketing Officer Debra Leipman-Yale, who is leaving the company after serving during a transitional period, firm notes...

You may also be interested in...



Revlon VP

Stephanie Klein Peponis to newly-created position of exec VP, chief planning and business development officer effective June 2, Revlon announces. Former VP and director of Boston Consulting Group will be responsible for supporting ongoing development and refinement of Revlon's business strategy, firm says. Reporting to CEO Jack Stahl, she will oversee planning processes, market research and analysis and evaluate new growth opportunities...

Hunt On For New Chair Of UK Regulator

Whoever takes over as chair of the Medicines and Healthcare products Regulatory Agency will play a key role in its plans to deliver a program of “ambitious business change.”

Perrigo Rolls Out US ProAir Rival

Perrigo has received US FDA approval for a generic version of Teva’s ProAir albuterol inhaler. The firm is immediately launching a “limited quantity” but is also ramping up production with partner Catalent to meet future demand.

UsernamePublicRestriction

Register

RS011545

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel